Catalyst Wire Dossier Catalyst Wire Dossier

Ucha-Shinki-Hwan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ucha-Shinki-Hwan, covering 2021-09-01 to 2021-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ucha-Shinki-Hwan on Korean Patients With Cold Hypersensitivity in the Hands and Feet-Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial [Phase 2, Phase 3]

See pricing